In mild patients, oral salicylazosulfapyridine (SASP) or 5-aminosalicylic acid (5-ASA) was given as the primary medical therapy.
内科治疗轻度患者以口服柳氮磺胺吡啶(SASP)/5-氨基水杨酸(5-ASA)为;
In mild patients, oral salicylazosulfapyridine (SASP) or 5-aminosalicylic acid (5-ASA) was given as the primary medical therapy.
内科治疗轻度患者以口服柳氮磺胺吡啶(SASP)/5-氨基水杨酸(5-ASA)为;
:以例、词分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。